Crescita Therapeutics (TSE:CTX) Stock Price Up 1.8% – Here’s What Happened

Crescita Therapeutics Inc. (TSE:CTX) shares rose 1.8% on Monday . The company traded as high as C$0.58 and last traded at C$0.57. Approximately 7,000 shares changed hands during trading, a decline of 33% from the average daily volume of 10,508 shares. The stock had previously closed at C$0.56.

Crescita Therapeutics Price Performance

The business’s 50 day moving average price is C$0.57 and its two-hundred day moving average price is C$0.59. The stock has a market cap of C$10.49 million, a P/E ratio of -3.87 and a beta of 1.69. The company has a current ratio of 2.70, a quick ratio of 2.29 and a debt-to-equity ratio of 5.77.

Insider Activity

In related news, Director Jose Darocha bought 86,000 shares of the business’s stock in a transaction dated Friday, December 27th. The shares were purchased at an average price of C$0.60 per share, with a total value of C$51,436.60. Insiders own 10.87% of the company’s stock.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.